SteelPeak Wealth’s ResMed RMD Stock Holding History

SteelPeak Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-907	Closed	-$203K	–	646
2025 Q1	$203K	Buy	907 +14	+2%	+$3.27K	0.01%	487
2024 Q4	$204K	Buy	+893	New	+$215K	0.01%	485
2021 Q4	–	Sell	-1,209	Closed	-$319K	–	462
2021 Q3	$319K	Buy	+1,209	New	+$331K	0.02%	324

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

SteelPeak Wealth's RMD Position: Q2 2025 in Review

SteelPeak Wealth sold out of ResMed (RMD) in Q2 2025, closing a stake of 907 shares — an estimated $203K sold.

SteelPeak Wealth first reported a position in RMD in Q3 2021 and held it in 3 quarters. The position peaked at $319K in Q3 2021. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

SteelPeak Wealth reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
SteelPeak Wealth sold 907 ResMed shares in Q2 2025, an estimated $203K.
SteelPeak Wealth first reported a position in ResMed in Q3 2021 and held it in 3 quarters.
SteelPeak Wealth's ResMed position peaked at $319K in Q3 2021.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on SteelPeak Wealth's 13F filing for Q2 2025, filed 23 Jul 2025.